PIOGLITAZONE-GLIMEPIRIDE 30-4

pioglitazone and glimepiride
$11.3183per EA

Strength

4; 30 mg/1; mg/1

NDC

66993082230

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Last Updated

4/22/2026

Approval Type

Authorized Generic (NDA)

FDA Application

NDA021925

On Market Since

8/4/2015

Pharmacological Classes

Peroxisome Proliferator Receptor alpha Agonist
Peroxisome Proliferator Receptor gamma Agonist
Peroxisome Proliferator-activated Receptor alpha Agonists
Peroxisome Proliferator-activated Receptor gamma Agonists
Sulfonylurea Compounds
Sulfonylurea
Thiazolidinedione
Thiazolidinediones

Price History

1W

0.0%

1M

+0.5%

3M

+0.1%

6M

-0.8%

1Y

+35.6%

3Y

+10.7%

5Y

+10.7%

All

+18.7%